✦ LIBER ✦

Hematologic Outcomes of Myelodysplastic Syndromes Treatment With Hypomethylating Agents in Community Practice

✍ Scribed by Rodolfo E. Bordoni; Bruce A. Feinberg; James W. Gilmore; Sally Haislip; James H. Jackson; Eileen Farrelly; Edward Kim; Deborah Buchner

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Practical Recommendations for Hypomethyl

✍ Steensma, David P.; Stone, Richard M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB

PCN115 Patterns of Care in Patients With

✍ Faria, C.; Chang, E.; Powers, A.; Cherepanov, D.; Broder, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Predicting the outcome of patients with

✍ Itzykson, Raphael; Fenaux, Pierre 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 228 KB

Novel therapeutic strategies using hypom

✍ Ishikawa, Takayuki 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 229 KB

Treatment of higher risk myelodysplastic

✍ Mahesh Seetharam; Alice C. Fan; Mai Tran; Liwen Xu; John P. Renschler; Dean W. F 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 395 KB

P-297 Hypomethylation agents in the trea

✍ Patel, K.; Singh, A.; Nandurkar, T.; Lehman, S.; Daji, A.; Gor, A.; Welsh, J.; N 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB